Brief: Star Combo Pharma Announces Expansion Of Manufacturing Capabilities At NSW Site
Sept 1 (Reuters) - Star Combo Pharma Ltd S66.AX :
* ANNOUNCES EXPANSION OF MANUFACTURING CAPABILITIES AT ITS
TGA-LICENSED NUTRACEUTICAL MANUFACTURING SITE AT NEW SOUTH WALES
* $11 MILLION WILL BE INVESTED IN ACQUISITION OF 13 NEW
PRODUCTION
LINES
Source: https://bit.ly/2YV54Lg
Further company coverage: S66.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Star Combo Pharma
See all newsBrief: Star Combo Pharma Announces Insurance Claim Settlement Of A$5 Million
Brief: Star Combo Pharma Says Outlook For FY2025 Is Positive
Brief: Star Combo Pharma Says HY Operating Loss Attributable A$4.4 Million
Brief: Star Combo Pharma Posts Q1 Fy23 Revenue Of A$6.55M
Australia's Star Combo Pharma plunges to record low on fire incident